ASEGUA THERAPEUTICS LLC 2025-04-16 Health serious FDA
Health · FDA · Recall #FDA-D-0313-2025
Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx… Recall
Issued April 16, 2025 · ASEGUA THERAPEUTICS LLC
In April 2025, ASEGUA THERAPEUTICS LLC recalled the Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
What you should do
- 1 Stop using Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact ASEGUA THERAPEUTICS LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- ASEGUA THERAPEUTICS LLC
- Category
- Health
- Recall date
- April 16, 2025
- Units affected
- Not reported
- Sold at
- US Nationwide
- Recall number
- FDA-D-0313-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- ASEGUA THERAPEUTICS LLC has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.